Archives of Clinical Infectious Diseases

Published by: Kowsar

Fatal Combination of Antibiotic and Calcium Channel Blocker Agents

Masoud Mardani 1 , *
Author Information
1 Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 24, 2013, 8 (2); ee17840
  • Published Online: April 17, 2013
  • Article Type: Editorial
  • Received: February 20, 2013
  • Accepted: March 23, 2013
  • DOI: 10.5812/archcid.17840

To Cite: Mardani M. Fatal Combination of Antibiotic and Calcium Channel Blocker Agents, Arch Clin Infect Dis. 2013 ; 8(2):ee17840. doi: 10.5812/archcid.17840.

Copyright © 2013, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnotes
References
  • 1. Pai MP, Graci DM, Amsden GW. Macrolide drug interactions: an update. Ann Pharmacother. 2000; 34(4): 495-513[PubMed]
  • 2. Westphal JF. Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. Br J Clin Pharmacol. 2000; 50(4): 285-95[PubMed]
  • 3. Gandhi S, Fleet JL, Bailey DG, McArthur E, Wald R, Rehman F, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA. 2013; 310(23): 2544-53[DOI][PubMed]
  • 4. Biaxin Filmtab (clarithromycin tablets, USP), Biaxin XL Filmtab (clarithromycin extended-release tablets), Biaxin Granules (clarithromycin for oral suspension, USP). 2013;
  • 5. Hunt WA, Perrone RD. Kidney Disease: A Guide for Living. 2011;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments